Safety and Efficacy of Single Bolus Anticoagulation with Enoxaparin for Chronic Hemodialysis. Results of an Open-Label Post-Certification Study

Publisher： Karger

E-ISSN： 1423-0143|27|4|211-217

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.27, Iss.4, 2004-09, pp. : 211-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Blood Volume- and Blood Temperature-Controlled Hemodialysis in Critically Ill Patients: A 6-Month, Case-Matched, Open-Label Study

By  

Blood Purification, Vol. 29, Iss. 3, 2009-12 ,pp. : 245-251

Karger

Access to resources Recommend Favorite

Regional Citrate Anticoagulation for Single-Needle Hemodialysis: A Prospective Clinical Study

By  

Blood Purification, Vol. 25, Iss. 5-6, 2007-11 ,pp. : 454-456

Karger

Access to resources Recommend Favorite

Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis

By  

American Journal of Nephrology, Vol. 43, Iss. 4, 2016-04 ,pp. : 229-236

Karger

Access to resources Recommend Favorite

Hemodialysis without Anticoagulation for a Patient with Chronic Disseminated Intravascular Coagulation

By  

Case Reports in Nephrology and Dialysis, Vol. 4, Iss. 1, 2014-02 ,pp. : 25-30

Karger

Access to resources Recommend Favorite

Barriers to Physical Activity in Chronic Hemodialysis Patients: A Single-Center Pilot Study in an Italian Dialysis Facility

By  

Kidney and Blood Pressure Research, Vol. 39, Iss. 2-3, 2014-07 ,pp. : 169-175

Karger

Access to resources Recommend Favorite